The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery
Official Title: An Open-label, Randomized, Non-comparative Phase 2 Study of ARV-471 or Anastrozole in Post-menopausal Women With ER+/HER2- Breast Cancer in the Neoadjuvant Setting
Study ID: NCT05549505
Brief Summary: This trial is a Phase 2 neoadjuvant study evaluating ARV-471 or anastrozole in post-menopausal women with ER+/HER2- localized breast cancer.
Detailed Description: This is a Phase 2, open-label, randomized, non-comparative proof of concept study of ARV-471 or anastrozole in participants with ER+/HER2- breast cancer amenable to definitive surgical resection. The main goal of this study is to evaluate the biological activity of ARV-471 and anastrozole, respectively.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Clinical Trial Site, Springdale, Arkansas, United States
Clinical Trial Site, Los Angeles, California, United States
Clinical Trial Site, Torrance, California, United States
Clinical Trial Site, Van Nuys, California, United States
Clinical Trial Site, Fort Lauderdale, Florida, United States
Clinical Trial Site, Fort Myers, Florida, United States
Clinical Trial Site, Orlando, Florida, United States
Clinical Trial Site, West Palm Beach, Florida, United States
Clinical Trial Site, Iowa City, Iowa, United States
Clinical Trial Site, Springfield, Massachusetts, United States
Clinical Trial Site, Saint Louis, Missouri, United States
Clinical Trial Site, Nashville, Tennessee, United States
Clinical Trial Site, Tacoma, Washington, United States
Clinical Trial Site, Batumi, , Georgia
Clinical Trial Site, Tbilisi, , Georgia
Clinical Trial Site, Tbilisi, , Georgia
Clinical Trial Site, Tbilisi, , Georgia
Clinical Trial Site, Augsburg, , Germany
Clinical Trial Site, Berlin, , Germany
Clinical Trial Site, Bonn, , Germany
Clinical Trial Site, Bottrop, , Germany
Clinical Trial Site, Chemnitz, , Germany
Clinical Trial Site, Dresden, , Germany
Clinical Trial Site, Erlangen, , Germany
Clinical Trial Site, Essen, , Germany
Clinical Trial Site, Essen, , Germany
Clinical Trial Site, Esslingen, , Germany
Clinical Trial Site, Mannheim, , Germany
Clinical Trial Site, Paderborn, , Germany
Clinical Trial Site, La Coruna, Galicia, Spain
Clinical Trial Site, San Cristobal de La laguna, Santa Cruz De Tenerife, Spain
Clinical Trial Site, Alicante, , Spain
Clinical Trial Site, Barcelona, , Spain
Clinical Trial Site, Barcelona, , Spain
Clinical Trial Site, Barcelona, , Spain
Clinical Trial Site, Castelló, , Spain
Clinical Trial Site, Córdoba, , Spain
Clinical Trial Site, Granada, , Spain
Clinical Trial Site, Granada, , Spain
Clinical Trial Site, Lleida, , Spain
Clinical Trial Site, Madrid, , Spain
Clinical Trial Site, Madrid, , Spain
Clinical Trial Site, Madrid, , Spain
Clinical Trial Site, Manresa, , Spain
Clinical Trial Site, Sevilla, , Spain
Clinical Trial Site, Sevilla, , Spain
Clinical Trial Site, Valencia, , Spain
Clinical Trial Site, Valencia, , Spain
Clinical Trial Site, Zaragoza, , Spain